Heritability of Proliferative Diabetic Retinopathy

Overview

Journal Diabetes

Specialty Endocrinology

Date 2008 Apr 30

PMID 18443200

Citations 75

Authors

Kustaa Hietala

Carol Forsblom

Paula Summanen

Per-Henrik Groop

Affiliations

Soon will be listed here.

Abstract

Objective: Diabetic nephropathy clusters in families, suggesting that genetic factors play a role in its pathogenesis. We investigated whether similar clustering exists for proliferative retinopathy in families with two or more siblings with type 1 diabetes.

Research Design And Methods: The FinnDiane Study has characterized 20% (4,800 patients) of adults with type 1 diabetes in Finland. In 188 families, there were at least two siblings with type 1 diabetes. Ophthalmic records were obtained for 369 of 396 (93%) and fundus photographs for 251 of 369 (68%) patients. Retinopathy was graded based on photographs and/or repeated ophthalmic examinations using the Early Treatment of Diabetic Retinopathy grading scale.

Results: Mean age at onset of diabetes was 14.3 +/- 10.2 years, and mean duration was 25.9 +/- 11.8 years. Proliferative retinopathy was found in 115 of 369 patients (31%). The familial risk of proliferative retinopathy was estimated in 168 of 188 sibships, adjusted for A1C, duration, and mean blood pressure. Proliferative retinopathy in the probands (48 of 168) was associated with an increased risk (odds ratio 2.76 [95% CI 1.25- 6.11], P = 0.01) of proliferative retinopathy in the siblings of probands (61 of 182). The heritability of proliferative retinopathy was h(2) = 0.52 +/- 0.31 (P < 0.05).

Conclusions: We found a familial clustering of proliferative retinopathy in patients with type 1 diabetes. The observation cannot be accounted for by conventional risk factors, suggesting a genetic component in the pathogenesis of proliferative retinopathy in type 1 diabetes.

Citing Articles

Genetic studies of type 2 diabetes, and microvascular complications of diabetes.

Imamura M, Maeda S Diabetol Int. 2024; 15(4):699-706.

PMID: 39469559 PMC: 11512959. DOI: 10.1007/s13340-024-00727-4.

Assessment of MIR200B Polymorphisms Association with Sight-Threatening Diabetic Retinopathy.

Zal N, Safi S, Ahmadieh H, Fekri S, Najafi S, Forouhari A J Curr Ophthalmol. 2024; 35(4):355-361.

PMID: 39281402 PMC: 11392297. DOI: 10.4103/joco.joco_287_22.

Genetic insights and emerging therapeutics in diabetic retinopathy: from molecular pathways to personalized medicine.

Pei X, Huang D, Li Z Front Genet. 2024; 15:1416924.

PMID: 39246572 PMC: 11378321. DOI: 10.3389/fgene.2024.1416924.

Identification of Genetic Variants for Diabetic Retinopathy Risk Applying Exome Sequencing in Extreme Phenotypes.

Zenteno J, Chacon-Camacho O, Ordonez-Labastida V, Miranda-Duarte A, Del Castillo C, Nava J Biomed Res Int. 2024; 2024:2052766.

PMID: 38249632 PMC: 10799704. DOI: 10.1155/2024/2052766.

Genomic profile of diabetic retinopathy in a north indian cohort.

Sikka R, Raina P, Soni R, Gupta H, Bhanwer A Mol Biol Rep. 2023; 50(12):9769-9778.

PMID: 37700140 DOI: 10.1007/s11033-023-08772-z.

References

McCarter R, Hempe J, Gomez R, Chalew S . Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004; 27(6):1259-64. DOI: 10.2337/diacare.27.6.1259. View

Seaquist E, Goetz F, Rich S, Barbosa J . Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med. 1989; 320(18):1161-5. DOI: 10.1056/NEJM198905043201801. View

Hallman D, Huber Jr J, Gonzalez V, Klein B, Klein R, Hanis C . Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005; 28(5):1163-8. DOI: 10.2337/diacare.28.5.1163. View

Deckert T, Simonsen S, Poulsen J . Prognosis of proliferative retinopathy in juvenile diabetics. Diabetes. 1967; 16(10):728-33. DOI: 10.2337/diab.16.10.728. View

Fagerudd J, Forsblom C, Pettersson-Fernholm K, Groop P . Implementation of guidelines for the prevention of diabetic nephropathy. Diabetes Care. 2004; 27(3):803-4. DOI: 10.2337/diacare.27.3.803. View

Davis M, Fisher M, Gangnon R, Barton F, Aiello L, Chew E . Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998; 39(2):233-52. View

Duggirala R, Williams J, Williams-Blangero S, Blangero J . A variance component approach to dichotomous trait linkage analysis using a threshold model. Genet Epidemiol. 1997; 14(6):987-92. DOI: 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G. View

ENGERMAN R, Kern T . Progression of incipient diabetic retinopathy during good glycemic control. Diabetes. 1987; 36(7):808-12. DOI: 10.2337/diab.36.7.808. View

. A protocol for screening for diabetic retinopathy in Europe. Retinopathy Working Party. Diabet Med. 1991; 8(3):263-7. View

10.

Laatikainen L, Summanen P, Ekstrand A, Groop L . Ophthalmological follow-up of diabetic patients after kidney transplantation. Ger J Ophthalmol. 1993; 2(1):24-7. View

11.

Looker H, Nelson R, Chew E, Klein R, Klein B, Knowler W . Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes. 2007; 56(4):1160-6. DOI: 10.2337/db06-1299. View

12.

Krolewski A, Fogarty D, Warram J . Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired?. Diabetes Res Clin Pract. 1998; 39 Suppl:S1-14. DOI: 10.1016/s0168-8227(98)00015-1. View

13.

. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998; 317(7160):703-13. PMC: 28659. View

14.

Lachin J, Genuth S, Cleary P, Davis M, Nathan D . Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000; 342(6):381-9. PMC: 2630213. DOI: 10.1056/NEJM200002103420603. View

15.

Uhlmann K, Kovacs P, Boettcher Y, Hammes H, Paschke R . Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2006; 114(6):275-94. DOI: 10.1055/s-2006-924260. View

16.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

17.

Keen K, Elston R . Robust asymptotic sampling theory for correlations in pedigrees. Stat Med. 2003; 22(20):3229-47. DOI: 10.1002/sim.1559. View

18.

Imperatore G, Hanson R, Pettitt D, Kobes S, BENNETT P, Knowler W . Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group. Diabetes. 1998; 47(5):821-30. DOI: 10.2337/diabetes.47.5.821. View

19.

. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998; 352(9131):837-53. View

20.

Khoury M, Beaty T, Liang K . Can familial aggregation of disease be explained by familial aggregation of environmental risk factors?. Am J Epidemiol. 1988; 127(3):674-83. DOI: 10.1093/oxfordjournals.aje.a114842. View